Oventus Medical Ltd. announce it has entered into a collaboration agreement with Zhuhai Blue Ocean Strategy Medical Co. Ltd. The collaboration agreement executed between Oventus and ZHBOS relates to Oventus' proprietary O2Vent TTM product, indicated for use during sleep to aid in the treatment of snoring and obstructive sleep apnoea (OSA). The agreement between the two parties details terms around clinical trials, training of relevant staff, achievement of relevant regulatory clearances and marketing preparations, as they pertain to the Chinese market. A formal distribution agreement for the O2VentTM T product in the Chinese market is intended to be executed by the parties in the second half of 2017.